Clinical Considerations in Renal Cell Carcinoma: Current Evidence, Guideline Recommendations, and a View to the Future

In this program experts review the recommended guidelines for managing operable advanced or metastatic renal cell carcinoma including the latest data on emerging therapies and adverse event management. Download the slidsesets from a live CME/CE/CPE-certified satellite symposium presented in Chicago at ASCO 2022 and read an expert commentary.

Share

Program Content

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by the National Comprehensive Cancer Network in collaboration with Clinical Care Options, LLC

Supporters

Supported by educational grants from

AVEO Pharmaceuticals, Inc.

Eisai Inc.

Exelixis

Merck Sharp & Dohme Corp.

Pfizer, Inc.